Gabriella Antignani

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Sara Feola, Jacopo Chiaro, Beatriz Martins et al. · eLife · 2022 · 39 citations · Full text

PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification

Sara Feola, Markus Haapala, Karita Peltonen et al. · ACS Nano · 2021 · 30 citations · Full text

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

Sara Feola, Salvatore Russo, Beatriz Martins et al. · Frontiers in Immunology · 2022 · 21 citations · Full text

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

Firas Hamdan, Beatriz Martins, Michaela Feodoroff et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 17 citations · Full text